Monciotti C G, Semplicini A, Morocutti A, Maioli M, Cipollina M R, Barzon I, Palaro C, Brocco E, Trevisan M, Fioretto P, Crepaldi G, Nosadini R
Department of Paediatrics, University of Padova, Italy.
Diabetologia. 1997 Jun;40(6):654-61. doi: 10.1007/s001250050730.
Pathogenetic mechanisms other than the quality of metabolic control may play a role in the development of diabetic nephropathy. Some cross-sectional studies have shown that elevated erythrocyte sodium-lithium countertransport (Na+/Li+ CT) activity may be linked to incipient or overt nephropathy in insulin-dependent diabetic (IDDM) patients. The aim of the present work was to ascertain if high erythrocyte Na+/Li+ CT activity anticipates the development of microalbuminuria in IDDM patients. Evaluation of this cation transport system was carried out in 159 normotensive, normoalbuminuric IDDM patients, who were divided into two groups: those with values above (Group A) and those with values below (Group B) the median level in the overall population (300 mumol/erythrocytes x h). A total of 79 patients in Group A and 80 in Group B underwent periodic examinations over a similar time period (5.2 years, range 3.3-7.4 years and 5.4 years, range 3.4-7.5 years, respectively). Median sodium-lithium countertransport activity was stable when evaluated after 2 and 4 years of follow-up. Only seven patients were excluded from the protocol because changes in their sodium-lithium countertransport activity placed them on the other side of the median value with respect to their baseline measurement. Thus, 152 patients completed the study (76 in Group A and 76 in Group B). Of the 76 patients in Group A, 17 developed persistent microalbuminuria (22.3%). The number of patients in Group B showing persistent microalbuminuria was significantly lower (4 of 76; 5.2%; p < 0.01). The sensitivity of erythrocyte Na+/Li+ CT in predicting the development of microalbuminuria was 85% and its specificity was 55%. Seven patients of Group A and five of Group B developed arterial hypertension. Subjects in Group A had significantly higher mean HbA1c values of twice yearly measurements than those in Group B (9.6 +/- 1.7 vs 8.3 +/- 1.7%, p < 0.002, mean +/- SD) despite similar daily insulin requirements. Systolic and diastolic blood pressure levels were also evaluated every 6 months and were significantly higher in the Group A than in the Group B patients, although on average within the normal range. The odds ratio for developing persistent microalbuminuria in IDDM with elevated baseline erythrocyte Na+/Li+ CT activity after adjustment for gender and baseline albumin excretion rate, and mean 6 monthly plasma creatinine, HbA1c and systolic and diastolic blood pressure levels was 4.2 (95% confidence intervals 2.0-11.1). It was also found that the percentage of offspring having both parents with Na+/Li+ CT activity above the median value was significantly higher in Group A than in Group B (Group A vs Group B: 35 vs 19%; p < 0.01). On the contrary the percentage of offspring whose erythrocyte Na+/Li+ CT was lower in both parents was lower in Group A than in Group B: 10 vs 38%, p < 0.01). Parents of Group A offspring had arterial hypertension more frequently than those of Group B. These results indicate that erythrocyte Na+/Li+ CT activity is a useful diagnostic tool in identifying normotensive, normoalbuminuric patients who may be predisposed to develop persistent microalbuminuria. This disorder in the cation transport system is associated with poor metabolic control, higher blood pressure, and male sex; it also appears to be, at least partly, genetically transmitted.
除代谢控制质量外,其他致病机制可能在糖尿病肾病的发展中起作用。一些横断面研究表明,红细胞钠-锂逆向转运(Na+/Li+ CT)活性升高可能与胰岛素依赖型糖尿病(IDDM)患者的早期或显性肾病有关。本研究的目的是确定红细胞Na+/Li+ CT活性升高是否预示IDDM患者微量白蛋白尿的发生。对159例血压正常、尿白蛋白正常的IDDM患者进行了该阳离子转运系统的评估,这些患者被分为两组:红细胞Na+/Li+ CT活性高于总体人群中位数水平的患者(A组)和低于中位数水平的患者(B组)(300 μmol/红细胞×小时)。A组79例患者和B组80例患者在相似的时间段内接受了定期检查(分别为5.2年,范围3.3 - 7.4年和5.4年,范围3.4 - 7.5年)。随访2年和4年后评估时,钠-锂逆向转运活性中位数保持稳定。只有7例患者被排除在研究方案之外,因为他们的钠-锂逆向转运活性变化使其相对于基线测量值处于中位数的另一侧。因此,152例患者完成了研究(A组76例,B组76例)。A组76例患者中,17例出现持续性微量白蛋白尿(22.3%)。B组出现持续性微量白蛋白尿的患者数量显著更低(76例中的4例;5.2%;p < 0.01)。红细胞Na+/Li+ CT预测微量白蛋白尿发生的敏感性为85%,特异性为55%。A组7例患者和B组5例患者出现动脉高血压。尽管每日胰岛素需求量相似,但A组患者每年两次测量的平均糖化血红蛋白(HbA1c)值显著高于B组(9.6±1.7 vs 8.3±1.7%,p < 0.002,平均值±标准差)。每6个月还评估收缩压和舒张压水平,A组患者显著高于B组患者,尽管平均处于正常范围内。在调整性别、基线白蛋白排泄率以及平均每6个月的血浆肌酐、HbA1c和收缩压与舒张压水平后,基线红细胞Na+/Li+ CT活性升高的IDDM患者发生持续性微量白蛋白尿的比值比为4.2(95%置信区间2.0 - 11.1)。还发现,父母双方Na+/Li+ CT活性均高于中位数的后代在A组中的比例显著高于B组(A组 vs B组:35% vs 19%;p < 0.01)。相反,父母双方红细胞Na+/Li+ CT均较低的后代在A组中的比例低于B组:10% vs 38%,p < 0.01)。A组后代的父母患动脉高血压的频率高于B组。这些结果表明,红细胞Na+/Li+ CT活性是识别可能易发生持续性微量白蛋白尿的血压正常、尿白蛋白正常患者的有用诊断工具。这种阳离子转运系统的紊乱与代谢控制不佳、血压升高和男性性别有关;它似乎也至少部分地通过基因传递。